Your browser doesn't support javascript.
loading
The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging.
Roberson, Lara; Shaharyar, Sameer; Aneni, Ehimen; Freitas, Wladimir; Blaha, Michael; Agatston, Arthur; Blumenthal, Roger; Santos, Raul D; Feiz, Hamid; Nasir, Khurram; Sposito, Andrei.
Afiliación
  • Roberson L; Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL USA.
  • Shaharyar S; Aventura Hospital & Medical Center, Aventura, FL USA.
  • Aneni E; Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL USA.
  • Freitas W; Cardiology Department, State University of Campinas School of Medicine Campinas, Sao Paulo, Brazil.
  • Blaha M; Johns Hopkins Hospital Ciccarone Preventive Cardiology Center, Baltimore, MD USA.
  • Agatston A; Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL USA.
  • Blumenthal R; Johns Hopkins Hospital Ciccarone Preventive Cardiology Center, Baltimore, MD USA.
  • Santos RD; Lipid Clinic- Heart Institute (InCor), University of São Paulo Medical School Hospital, Sao Paulo, Brazil.
  • Feiz H; Aventura Hospital & Medical Center, Aventura, FL USA.
  • Nasir K; Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL USA ; Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL USA ; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, M
  • Sposito A; Cardiology Division, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Cidade Universitária, Campinas, SP 13084-971 Brazil.
Diabetol Metab Syndr ; 6(1): 121, 2014.
Article en En | MEDLINE | ID: mdl-25411583
BACKGROUND: Current literature has elucidated a new phenotype, metabolically healthy obese (MHO), with risks of cardiovascular disease similar to that of normal weight individuals. Few studies have examined the MHO phenotype in an aging population, especially in association with subclinical CVD. RESEARCH DESIGN AND METHODS: This cross sectional study population consisted of 208 octogenarians and older. Anthropometrics, biochemical, and radiological parameters were measured to assess obesity, metabolic health (assessed by the National Cholesterol Education Program -Adult Treatment Panel (NCEP-ATP III) criteria), and subclinical measures of CVD. RESULTS: The prevalence of MHO was 13.5% (N = 28). No significant association with MHO was noted for age, coronary artery calcium score, cIMT, or hs-CRP > 3 mg/dl (p = NS). CONCLUSIONS: Our results suggest that the MHO phenotype exists in the elderly; however, subclinical CVD measures were not different in sub-group analysis suggesting traditional metabolic risk factor algorithms may not be accurate in the very elderly.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: America do sul / Brasil Idioma: En Revista: Diabetol Metab Syndr Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: America do sul / Brasil Idioma: En Revista: Diabetol Metab Syndr Año: 2014 Tipo del documento: Article